Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salovum and SPC-Flakes for Abemaciclib-induced Diarrhea
NCT06152471Phase 3Unknown
- Start
- Jun 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Occurrence of Abemaciclib induced diarrhea - STIDAT at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT06152471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06152471.